ICUI Stock Analysis: Buy, Sell, or Hold?
ICUI - ICU Medical Inc
$182.84
0.31 (0.17%)
▲
5d:
-0.08%
30d:
+19.15%
90d:
+39.24%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When ICUI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ICUI shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ICUI shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$219.97
Based on 7.1% avg growth
INTRINSIC VALUE TODAY
$136.59
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ICUI is currently trading at $182.84, which is considered extended relative to its 30-day fair value range of $160.04 to $181.66. From a valuation perspective, the stock is trading at a premium (Forward PE: 18.9) compared to its historical average (16.2). At these levels, the market is pricing in 5.3% annual earnings growth.
Technical Outlook: Technically, ICUI is in a strong uptrend. Immediate support is located at $177.02, while resistance sits at $189.29.
Market Sentiment: ICUI scores 22/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ICUI is in a strong uptrend. Immediate support is located at $177.02, while resistance sits at $189.29.
Market Sentiment: ICUI scores 22/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$160.04 -
$181.66
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
27.1%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (22/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($193.38)
- BULLISH: Expecting earnings turnaround to 5.3% growth with 0.5% revenue growth
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$160.04 -
$181.66
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$177.02
Resistance Level
$189.30
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.95
Wall Street Target
$193.38
(+5.8%)
Revenue Growth (YoY)
0.5%
Earnings Growth (YoY)
-46.9%
Profit Margin
1.4%
Valuation Premium vs History
+5.3% premium
PE vs Historical
19.0 vs 16.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.3%
(market-implied from PE analysis)
1-Year Target
$192.53
(+5%)
2-Year Target
$202.73
(+11%)
3-Year Target
$213.48
(+17%)
3-Yr Target (if PE normalizes)
(PE: 19→16)
PE COMPRESSION
$182.46
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 10.2%)
$259.18
(+42%)
Base:
(SPY PE: 19.0, Growth: 10.2%)
$244.77
(+34%)
Bear:
(PE: 16.1, Growth: 10.2%)
$208.05
(+14%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (21x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Forward PE: 21.37 | Forward EPS (Implied): $8.56
Bull Case
$220.78
(+21%)
Analyst growth 15.0%, PE expands to 22.4
Base Case
$182.84
(0%)
Market implied 0.0%, PE stable at 21.4
Bear Case
$139.87
(-24%)
Severe decline -15.0%, PE contracts to 19.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 23, 2026 1:27 AM ET
Data refreshes hourly during market hours. Next update: 2:27 AM
Data refreshes hourly during market hours. Next update: 2:27 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICUI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 46 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$86 | 37 SELL |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$405 | 66 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 45 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$247 | 41 HOLD |
